Industry News
Many Hispanics Are Unwilling To Participate In Cancer Screenings, Fear Being A 'Guinea Pig'
Jan 11, 2013
When researchers at Moffitt Cancer Center and colleagues conducted a random telephone survey among blacks, whites and Hispanics in New York, Baltimore and San Juan, Puerto Rico, they found that Hispanics are nearly twice as likely to report that fear of being used as a "guinea pig" and lack of trust in medical professionals contribute in being unwilling to participate in cancer screenings... Read More
Detecting Ovarian, Endometrial Cancers Using "PapGene" Test
Jan 11, 2013
Using cervical fluid obtained during routine Pap tests, scientists at the Johns Hopkins Kimmel Cancer Center have developed a test to detect ovarian and endometrial cancers. In a pilot study, the "PapGene" test, which relies on genomic sequencing of cancer-specific mutations, accurately detected all 24 (100 percent) endometrial cancers and nine of 22 (41 percent) ovarian cancers... Read More
Microscopic Hematuria Found To Be An Unreliable Indicator Of Renal Or Bladder Cancer
Jan 11, 2013
The presence of microscopic hematuria - blood found in urine that can't be seen by the naked eye - does not necessarily indicate the presence of cancer, according to a Kaiser Permanente Southern California study published in the journal Mayo Clinic Proceedings... Read More
Spin And Bias In Published Studies Of Breast Cancer Trials
Jan 11, 2013
Spin and bias exist in a high proportion of published studies of the outcomes and adverse side-effects of phase III clinical trials of breast cancer treatments, according to new research published in the cancer journal Annals of Oncology [1] today (Thursday)... Read More
Many Published Studies Of Breast Cancer Trials Use Spin And Bias
Jan 11, 2013
Spin and bias exist in a high proportion of published studies of the outcomes and adverse side-effects of phase III clinical trials of breast cancer treatments, according to new research published in the cancer journal Annals of Oncology [1]... Read More
Using Sickle Cells To Fight Aggressive Cancer Tumors
Jan 11, 2013
By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed a way to deploy the misshapen red blood cells to fight cancer tumors... Read More
'Intermittent Dosing' Strategy In Lab Mice Suggests Simple Way To Help People With Late-Stage Melanoma
Jan 11, 2013
Researchers in California and Switzerland have discovered that melanomas that develop resistance to the anti-cancer drug vemurafenib (marketed as Zelboraf), also develop addiction to the drug, an observation that may have important implications for the lives of patients with late-stage disease... Read More
Potential To Dramatically Reduce The Number Of Patients Needed And Time Required To Test Drugs For Lung Cancer Prevention
Jan 10, 2013
Testing medicines to prevent lung cancer requires treating many thousands of high-risk individuals and then waiting 5, 10 or 15 years to discover which of them develop cancer and which, if any, experience survival benefit from the treatment... Read More
HPV Associated Cancer Incidence Rates Point To Needed Efforts To Increase HPV Vaccination Coverage
Jan 10, 2013
Despite the decline in cancer death rates in the U.S., there is an increase in incidence rates for cancers associated with human papillomavirus (HPV) infection and more efforts are needed to increase HPV vaccination coverage levels to prevent the occurrence of these cancers in the future according to a study published January 7 in the Journal of the National Cancer Institute... Read More
Cancer Drug "Holiday" May Extend Patient Survival
Jan 10, 2013
New research on mice shows that drug-resistant melanoma tumors shrink when treatment is interrupted, or given a "holiday", suggesting that altering the dose pattern of cancer drug treatment in this manner could be a simple way to extend survival in human patients with late-stage disease. However, only human trials can verify if this is the case... Read More
Previous Page Next Page